The Impact of NLRP3 Inflammasome on Osteoblasts and Osteogenic Differentiation: A Literature Review
Ziyuan Yang,Jiaan Xu,Ting Kang,Xuepeng Chen,Chengcong Zhou
DOI: https://doi.org/10.2147/jir.s457927
IF: 4.5
2024-04-30
Journal of Inflammation Research
Abstract:Ziyuan Yang, 1, 2 Jiaan Xu, 3 Ting Kang, 1, 2 Xuepeng Chen, 1, 2 Chengcong Zhou 4 1 Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Hangzhou, 310006, People's Republic of China; 2 Clinical Research Center for Oral Diseases of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, 310006, People's Republic of China; 3 College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China; 4 The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China Correspondence: Chengcong Zhou, The First Affiliated Hospital of Zhejiang Chinese Medical University, 548 Binwen Road, Hangzhou, 310053, People's Republic of China, Email Xuepeng Chen, Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, 166 North Qiutao Road, Hangzhou, 310006, People's Republic of China, Email Osteoblasts (OBs), which are a crucial type of bone cells, derive from bone marrow mesenchymal stem cells (MSCs). Accumulating evidence suggests inflammatory cytokines can inhibit the differentiation and proliferation of OBs, as well as interfere with their ability to synthesize bone matrix, under inflammatory conditions. NLRP3 inflammasome is closely associated with cellular pyroptosis, which can lead to excessive release of pro-inflammatory cytokines, causing tissue damage and inflammatory responses, however, the comprehensive roles of NLRP3 inflammasome in OBs and their differentiation have not been fully elucidated, making targeting NLRP3 inflammasome approaches to treat diseases related to OBs uncertain. In this review, we provide a summary of NLRP3 inflammasome activation and its impact on OBs. We highlight the significant roles of NLRP3 inflammasome in regulating OBs differentiation and function. Furthermore, current available strategies to affect OBs function and osteogenic differentiation targeting NLRP3 inflammasome are listed and analyzed. Finally, through the prospective discussion, we seek to provide novel insights into the crucial role of NLRP3 inflammasome in diseases related to OBs and offer valuable information for devising treatment strategies. Keywords: osteoblast, pyroptosis, NLRP3 inflammasome, osteogenic differentiation Skeletal development and bone remodeling rely on a delicate balance between the bone formation process executed by osteoblasts (OBs) and the bone resorption process carried out by osteoclasts (OCs), 1 OCs initiates the resorption of existing bone, thus triggering a subsequent process of bone formation by OBs. 2 During bone remodeling, bone marrow mesenchymal stem cells (MSCs) undergo differentiation into OBs, which subsequently mature into osteocytes. 3 Importantly, many diseases, such as osteoporosis (OP), 4,5 periodontitis, 6 osteoarthritis (OA), 7,8 are characterized by the disruption of bone remodeling processes, furthermore, calcification, a risk factor for the occurrence of multiple diseases such as atherosclerosis and nephrocalcinosis, 9,10 is highly related to osteogenic differentiation, in calcified blood vessels or tissues, many cells become activated and undergo a process of trans-differentiation into other cell types, such as OBs, which express bone markers and matrix proteins including osteopontin (OPN) and runt-related transcription factor 2 (RUNX2), which ultimately lead to calcification. 11,12 Therefore, it is essential to further elucidate mechanisms that affect OBs function and differentiation to facilitate the development of novel therapeutic strategies for these diseases. Figure 1 A schematic model depicting the activation process of NLRP3 inflammasome and the impact on OBs, osteogenic differentiation and osteogenic microenvironment. Various intracellular and extracellular stimuli activate NLRP3 inflammasome, leading to the release of inflammatory factors and alterations in the expression of markers associated with osteogenic differentiation. Consequently, this impedes the functionality and osteogenic differentiation capacity of OBs and their precursor cells, MSCs. Figure 2 Potential therapeutic strategies by inhibiting NLRP3 inflammasome in OBs-related diseases. Pyroptosis, an inflammatory and programmed mode of cell death (PCD), is composed of "pyro" and "ptosis". "Pyro" means fire, indicating the properties of inflammation, and "ptosis" means falling, which is consistent with other forms of programmed cell death. 13 This process is inherently dependent on inflammation and can be triggered by variou -Abstract Truncated-
immunology